Cinven plans further Dx consolidation after Labco acquisition
This article was originally published in Clinica
Private equity firm Cinven plans to contribute to the further consolidation of the diagnostic labs sector once it has completed the acquisition of Labco, one of Europe’s largest diagnostic lab operators.
You may also be interested in...
By stalking Stada, Cinven seems to be planning to use the German generics group as a base that can support later carve-outs of mature and undervalued products from larger pharma companies - but it faces a rival bidder in Advent, and more suitors could yet appear.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.